Heart risks in adrenal tumor patients under the microscope
NCT ID NCT07182175
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 150 patients with functional adrenal tumors to see how their heart and blood pressure change before and after surgery. Researchers will use heart ultrasounds and blood pressure monitoring to understand recovery and risks. The goal is to help doctors choose better medicines and make safer surgical plans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better manage heart risks and choose safer treatments for patients with adrenal tumors before and after surgery.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all patients or lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADRENAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University First Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable tech puts hormone health to the test
- New scan could replace risky vein test for Hormone-Driven high blood pressure
- New screening strategy could speed diagnosis of inherited aldosteronism
- Alcohol injection into adrenal tumors may offer surgery-free blood pressure control
- Sharper blood test could uncover hidden cause of high blood pressure
- New drug may offer safer option for Hormone-Driven high blood pressure